J0760 HCPCS Level II code: Injection, colchicine, per 1 mg
CMS terminated J0760: its last date of service was Dec 31, 2016. It stays here for looking up older claims; newer services need a current code.
Official description
J0760Injection, colchicine, per 1 mg
Short description: Colchicine injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J0760 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
- Terminated after
- Dec 31, 2016
Where J0760 sits
- 1J codesDrugs administered other than orally
- 2Terminated J0760Injection, colchicine, per 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J0760 still valid?
No. CMS terminated J0760; its last date of service was Dec 31, 2016. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J0760?
CMS lists J0760’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0760
All J codesJ0744Injection, ciprofloxacin for intravenous infusion, 200 mgJ0745Injection, codeine phosphate, per 30 mgJ0750Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)J0751Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)J0752Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)J0759Injection, clevidipine butyrate, 1 mgJ0770Injection, colistimethate sodium, up to 150 mgJ0775Injection, collagenase, clostridium histolyticum, 0.01 mgJ0780Injection, prochlorperazine, up to 10 mgJ0791Injection, crizanlizumab-tmca, 5 mgJ0795Injection, corticorelin ovine triflutate, 1 microgramJ0799Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified